BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26979828)

  • 1. The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer.
    Ladoire S; Enot D; Senovilla L; Ghiringhelli F; Poirier-Colame V; Chaba K; Semeraro M; Chaix M; Penault-Llorca F; Arnould L; Poillot ML; Arveux P; Delaloge S; Andre F; Zitvogel L; Kroemer G
    Autophagy; 2016 May; 12(5):864-75. PubMed ID: 26979828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer.
    Ladoire S; Penault-Llorca F; Senovilla L; Dalban C; Enot D; Locher C; Prada N; Poirier-Colame V; Chaba K; Arnould L; Ghiringhelli F; Fumoleau P; Spielmann M; Delaloge S; Poillot ML; Arveux P; Goubar A; Andre F; Zitvogel L; Kroemer G
    Autophagy; 2015; 11(10):1878-90. PubMed ID: 26506894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive impact of autophagy in human breast cancer cells on local immunosurveillance.
    Ladoire S; Enot D; Senovilla L; Chaix M; Zitvogel L; Kroemer G
    Oncoimmunology; 2016 Jun; 5(6):e1174801. PubMed ID: 27471653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate.
    Ladoire S; Senovilla L; Enot D; Ghiringhelli F; Poirier-Colame V; Chaba K; Erdag G; Schaefer JT; Deacon DH; Zitvogel L; Slingluff CL; Kroemer G
    Oncoimmunology; 2016 Jun; 5(6):e1160193. PubMed ID: 27471635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC3B in Malignant Cells Correlates With Immune Infiltrate in Hypopharyngeal Squamous Cell Carcinoma.
    Gao S; Chen J; Han X; Wei D; Wu Z; Gao C
    Technol Cancer Res Treat; 2020; 19():1533033820970664. PubMed ID: 33176581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes.
    Liu F; Lang R; Zhao J; Zhang X; Pringle GA; Fan Y; Yin D; Gu F; Yao Z; Fu L
    Breast Cancer Res Treat; 2011 Nov; 130(2):645-55. PubMed ID: 21717105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic expression of high mobility group B1 (HMGB1) is associated with tumor-infiltrating lymphocytes (TILs) in breast cancer.
    Lee HJ; Kim A; Song IH; Park IA; Yu JH; Ahn JH; Gong G
    Pathol Int; 2016 Apr; 66(4):202-9. PubMed ID: 26922571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection.
    Wang B; Xu D; Yu X; Ding T; Rao H; Zhan Y; Zheng L; Li L
    Ann Surg Oncol; 2011 Sep; 18(9):2585-93. PubMed ID: 21347781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells.
    Ladoire S; Arnould L; Apetoh L; Coudert B; Martin F; Chauffert B; Fumoleau P; Ghiringhelli F
    Clin Cancer Res; 2008 Apr; 14(8):2413-20. PubMed ID: 18413832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
    Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
    BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveolin-1 functions as a key regulator of 17β-estradiol-mediated autophagy and apoptosis in BT474 breast cancer cells.
    Wang R; He W; Li Z; Chang W; Xin Y; Huang T
    Int J Mol Med; 2014 Sep; 34(3):822-7. PubMed ID: 25017566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral regulatory T cells as an independent predictive factor for pathological complete response to neoadjuvant paclitaxel followed by 5-FU/epirubicin/cyclophosphamide in breast cancer patients.
    Oda N; Shimazu K; Naoi Y; Morimoto K; Shimomura A; Shimoda M; Kagara N; Maruyama N; Kim SJ; Noguchi S
    Breast Cancer Res Treat; 2012 Nov; 136(1):107-16. PubMed ID: 22986814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Runx2 in facilitating autophagy in metastatic breast cancer cells.
    Tandon M; Othman AH; Ashok V; Stein GS; Pratap J
    J Cell Physiol; 2018 Jan; 233(1):559-571. PubMed ID: 28345763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status.
    Chung YR; Kim HJ; Jang MH; Park SY
    Breast Cancer Res Treat; 2017 Feb; 161(3):409-420. PubMed ID: 27913931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy.
    Vacchelli E; Semeraro M; Enot DP; Chaba K; Poirier Colame V; Dartigues P; Perier A; Villa I; Rusakiewicz S; Gronnier C; Goéré D; Mariette C; Zitvogel L; Kroemer G
    Oncotarget; 2015 Aug; 6(25):20840-50. PubMed ID: 26369701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of FOXP3 expression in triple-negative breast cancer.
    Lee S; Cho EY; Park YH; Ahn JS; Im YH
    Acta Oncol; 2013 Jan; 52(1):73-81. PubMed ID: 23075422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-mobility group box 1 released by autophagic cancer-associated fibroblasts maintains the stemness of luminal breast cancer cells.
    Zhao XL; Lin Y; Jiang J; Tang Z; Yang S; Lu L; Liang Y; Liu X; Tan J; Hu XG; Niu Q; Fu WJ; Yan ZX; Guo DY; Ping YF; Wang JM; Zhang X; Kung HF; Bian XW; Yao XH
    J Pathol; 2017 Nov; 243(3):376-389. PubMed ID: 28802057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival.
    Ladoire S; Mignot G; Dabakuyo S; Arnould L; Apetoh L; Rébé C; Coudert B; Martin F; Bizollon MH; Vanoli A; Coutant C; Fumoleau P; Bonnetain F; Ghiringhelli F
    J Pathol; 2011 Jul; 224(3):389-400. PubMed ID: 21437909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1(+) immune cell infiltration inversely correlates with survival of operable breast cancer patients.
    Sun S; Fei X; Mao Y; Wang X; Garfield DH; Huang O; Wang J; Yuan F; Sun L; Yu Q; Jin X; Wang J; Shen K
    Cancer Immunol Immunother; 2014 Apr; 63(4):395-406. PubMed ID: 24514954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.